KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

Published:2025-07 Issue: Volume:57 Page:102421
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Abuelafia Analia Meilerman,Santofimia-Castaño Patricia,Estaras Matias^ORCID,Grasso Daniel^ORCID,Chuluyan Eduardo^ORCID,Lomberk Gwen^ORCID,Urrutia Raul,Dusetti Nelson,Fraunhoffer Nicolas,Iovanna Juan^ORCID

Funder

Institut National Du Cancer

Institut National de la Santé et de la Recherche Médicale

Centre de Recherche en Cancerologie de Marseille

Publisher

Elsevier BV

Reference59 articles.

1. Estimated projection of US cancer incidence and death to 2040;Rahib;JAMA Netw. Open. Am. Med. Assoc.,2021

2. Therapeutic developments in pancreatic cancer: current and future perspectives;Neoptolemos;Nat. Rev. Gastroenterol. Hepatol,2018

3. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer;Conroy;N. Engl. J. Med.,2018

4. Combination chemotherapy in advanced adrenocortical carcinoma;Fassnacht;N. Engl. J. Med,2012

5. The pancreas cancer microenvironment;Feig;Clin. Cancer Res,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP